腸内フローラとメタボリックシンドローム

出版社: 医薬出版
著者:
発行日: 2010-10-20
分野: 臨床医学:内科  >  消化器一般
ISBN: 9784990094072
電子書籍版: 2010-10-20 (初版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:8~14営業日

5,280 円(税込)

電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

2,640 円(税込)

商品紹介

第18回腸内フローラシンポジウムの記録。腸内フローラがどのようなメカニズムで肥満や糖尿病などと関わるかについて興味ある話題が提供された。

目次

  • 腸内フローラとメタボリックシンドローム

    ―目次―

    1.メタボリックシンドロームの基礎と臨床
    2.ヒトと微生物のトップダウンシステム生物学:
      個人別健康管理から分子疫学まで
    3.肥満に起因した代謝障害の発症に関与する腸内細菌叢:
      腸管透過性に及ぼす影響について
    4.肥満と腸内細菌叢:ホメオスタシス、免疫および
      細菌叢との共進化の影響
    5.バイオフィルム形成歯周病原性細菌と
      メタボリックシンドロームの密接な関係
    6.食欲、消化管機能と消化管フローラ
    7.プロバイオティクスとメタボリックシンドローム:
      インスリン抵抗性に対するプロバイオティクスの有用性

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1. メタボリックシンドロームの基礎と臨床

P.7 掲載の参考文献

2. ヒトと微生物のトップダウンシステム生物学 : 個人別健康管理から分子疫学まで

P.11 掲載の参考文献
1) Nicholson JK, Connelly J, Lindon J, Holmes E:Natare Rev Drug Disc 1(2):153-161,2002
2) Nicholson JK:Molecular Systems Biology(3):1-6,2006
4) Clayton TA, Nicholson JK, et al.:Nature 440 (20):1073-1078,2006
5) Clayton TA, Nicholson JK, et al.:PNAS(in press), 2009
9) Wei J. Nicholson J.K., et al.:Nature Reviews Drug Discovery 7(2):123-129,2008

3. 肥満に起因した代謝障害の発症に関与する腸内細菌叢 : 腸管透過性に及ぼす影響について

P.16 掲載の参考文献
1) Cani PD & Delzenne NM:Interplay between obesity and associated metabolic disorders:new insights into the gut micro-biota. Curr Opin Pharmacol 9:737-743,2009
3) Vreugdenhil AC, Rousseau CH, Hartung T, Greve JW, Buurman WA, et al.:Lipopolysaccharide(LPS)-binding protein mediates LPS detoxification by chylomicrons. J Immunol 170:1399-1405,2003
4) Ghoshal S, Witta J, Zhong J, de VW & Eckhardt E:Chylomicrons promote intestinal absorption of lipopolysaccharides. J. Lipid Res,2008
9) Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD & Gordon JI:Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 1O2:11070-11075,2005
13) Gibson, GR & Roberfroid, MB:Dietary modulation of the human colonic microbiota:introducing the concept of prebi-otics.J Nutr 125:1401-1412,1995
15) Wang Z, Xiao G, Yao Y, Guo S, Lu K & Sheng Z:The role of bifidobacteria in gut barrier function after thermal injury-in rats. J Trauma 61:650-657,2006
16) Wang ZT, Yao YM, Xiao GX & Sheng ZY:Risk factors of development of gut-derived bacterial translocation in thermal-ly injured rats. World J Gastroenterol. 10:1619-1624,2004
17) Brun P, Castagliuolo I, Leo VD, Buda A, Pinzani M, Palu G & Martines D:Increased intestinal permeability in obese mice :new evidence in the pathogenesis of nonalcoholic steatohepatitis.Am J Physiol Gastrointest Liver Physiol 292:G518-G525,2007
18) Cani PD, Possemiers S, Van de WT, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck AM, et al.:Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58:1091-1103,2009
20) Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, De BF, Neyrinck AM & Delzenne NM:Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90:1236-1243,2009

4. 肥満と腸内細菌叢 : ホメオスタシス, 免疫系および細菌叢との共進化の影響

P.23 掲載の参考文献
1) De Filippo C, Cavalieri D, DiPaola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G and Lionetti P:Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl ACad SCi USA 107:14691-14696,2010
6) Michetti P, Mahan MJ, Slauch JM, Mekalanos JJ and Neutra MR:Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect Immun 60:1786-1792,1992
9) Peterson DA, McNulty NP, Guruge JL and Gordon JI:IgA response to symbiotic bacteria as a mediator of gut homeosta-sis. Cell Host Microbe 2:328.339,2007
12) Suzuki K, Meek B, Doi Y, Muramatsu M, Chiba T, Honjo T and Fagarasan S:Aberrant expansion of segmented fila-mentous bacteria in IgA-deficient gut.Proc Natl Acad Sci USA 101:1981-1986,2004
13) Tumbaugh PJ, Backhed F, Fulton L and Gordon JI:Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3:213-223,2006

5. バイオフィルム形成歯周病原性細菌とメタボリックシンドロームの密接な関係

P.36 掲載の参考文献
1) Kigure T et al.:J Periodont Res 30:332-341,1995
2) Saito Y et al.:Ora Microbiol Immunol.23:1-6,2008
3) Shihara K et al.:FEMS Micobiol Lett 197:23-27,2001
5) Okuda K, Ishihara K., Kato T:Oral Diseases 10:512,2004
6) Robert J Genco:Scientific American:2006
7) Kato T et al.:FEMS Immun Medical Microbiol 47:262-266,2006
8) Saito A et al.:FEMS Immun Med Microbiol 54:349-355,2008
9) Ishihara K, Okuda K:FEMS Microbio Lett 181:199-204,1999
10) Yamazaki T et al.:Micro Infect 8:1758-1763,2006
11) Okuda K et al.:J Clin Microbiol 39:1114-1115,2004
12) Ishihara K et al.:J Clin Microbiol 42:1313-1315,2004
13) Li L et al.:Circulation 105:861-867,2002

6. 食欲, 消化管機能と消化管フローラ

P.43 掲載の参考文献
1) Suzuki H, Hibi T, Marshall BJ:Helicobactor pylori:present status and future prospects in Japan.J Gastroenterol 42:1-15,2007
2) Suzuki H, Iwasaki E, Hibi T:Helicobactor pylori and gastric cancer. Gastric Cancer 12:79-87,2009
4) Mori M, Suzuki H, Masaoka T et al.:Intravenous ghrelin administration enhances gastric acid secretion-evaluation using wireless pH capsule. Aliment Pharmacol Ther Symp Ser 2:96-103,2006
7) Nishizawa T, Suzuki H, Masaoka T et al.:Emotional stress enhanced ghrelin secretion from the stomach.J Clin Biochem Nature 38:33-37,2006
8) Nishizawa T, Suzuki H, Nomoto Y et al.:Enhanced plasma ghrelin levels in patients with functional dyspepsia. Aliment Pharmacol Ther 24(Suppl.4):104-110,2006
9) Suzuki H, Minegishi Y, Nomoto Y et al.:Down-regulation of a morphogen(sonic hedgehog)gradient in the gastric epithe-lium of Helicobactor pylori-infected Mongolian gerbils.J Pathol 206:186-197,2005
10) Suzuki H, Masaoka T, Hosoda H et al.:Helicobactor pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut 53:187-194,2004
11) Nishizawa T, Suzuki H, Nakagawa I et al.:Early Helicobactor pylori eradication restores sonic hedgehog expression in the gastric mucosa of Mongolian gerbils. Digestion 79:99-108,2009
12) Suzuki H, Masaoka T, Sasaki G et al.:Improvement of gastrointestinal quality of life scores in cases of Helicobactor-pylori-positive functional dyspepsia after successful eradication therapy.J Gastroenterol Hepatol 20:1652-1660,2005
13) Nishizawa T, Suzuki H, Nomoto Y et al.:Enhanced plasma ghrelin levels in patients with functional dyspepsia.Aliment Pharmacol Ther Symp Ser 1:2006
14) Mazzoleni LE, Sander GB, Ott EA et al.:Clinical outcomes of eradication of Helicobactor pylori in nonulcer dyspepsia-in a population with a high prevalence of infection:results of a 12-month randomized, double blind, placebo-controlled study. Dig Dis Sci 51:89-98,2006
15) Moayyedi P, Soo S, Deeks J et al.:Eradication of Helicobactor pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev CD002096,2006

7. プロバイオティクスとメタボリックシンドローム : インスリン抵抗性に対するプロバイオティクスの有用性

P.53 掲載の参考文献
1) Bakhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI:The gut microbiota as an envi-ronmental factor that regulates fat storage. Proc Natl Acad Sci USA 101:15718-15723,2004
5) Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M, Evans M, Harte AL and Kumar S: Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292:E740-E747,2007
7) Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, Lee J, Goldfine AB, Benoist C, Shoelson S and Mathis D: Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters.Nat Med 15:930-939.2009
8) Ley RE, Bakhed F, Turnbaugh P, Lozupone CA, Knight RD and Gordon JI:Obesity alters gut microbial ecology.Proc Natl Acad Sci USA 102:11070-11075,2005
9) Matsuzaki T, Ohta T, Hashimoto S and Yokokura T:Distribution of orally administered Lactobacillus casei in diabetic mice. KISO TO RINSYO 31:2977-2982,1997
11) Ma X, Hua J and Li Z:Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells.J Hepatol 49:821-830,2008
12) Miyazaki K and Matsuzaki T:Health properties of milk fermented with Lactobacillus casei strain Shirota(LcS). In Handbook of Fermented Functional Foods.2nd edition. Farnworth ER(eds)pp 165-208. Boca Raton:CRC Press,2008
14) Paoletti R, Bolego C, Poli A and Cignarella A:Metabolic syndrome, inflammation and atherosclerosis.Vasc Health Risk Manag 2:145-152,2006
16) Tanida M,Shen J,Maeda K,Horii Y,Yamano T,Fukushima Y and Nagai K:High-fat diet-induced obesity is attenuated by probiotic strain Lactobacillus paracasei ST11 (NCC2461)in rats.Obesity Res Clin Pract 2:159-169,2008

最近チェックした商品履歴

Loading...